Dynamic PET acquisition-a Quantitative Technique for Grading of Malignant Tumors and Prediction of Response to Treatment

Dynamic FDG-PET in Aggressive Lymphoma and Pancreas Cancer

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00294840

Enrollment

Registered

2006-02-22

Start date

2006-08-31

Completion date

2010-04-30

Last updated

2010-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic Cancer

Brief summary

To assess a quantitative kinetic model of FDG uptake measurement using PET in patients with aggressive Non-Hodgkin's lymphoma and cancer of the pancreas, malignancies with known variability in disease aggressiveness and prognosis, for optimized tailoring of the therapeutic strategy in the individual patient.

Interventions

DEVICEPET-CT

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* age\>18 * newly diagnosed untreated aggressive NHL * newly diagnosed untreated cancer of pancreas

Exclusion criteria

* none

Design outcomes

Primary

Measure	Time frame
The impact of the imaging modality on patient management	5 years

Secondary

Measure	Time frame
patient management	10 years

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026